Bilateral Primary Breast Cancer: A Case of Synchronous Diagnosis and Management of Ductal Carcinoma In Situ and Invasive Ductal Carcinoma
- PMID: 40554446
- DOI: 10.12968/hmed.2024.1013
Bilateral Primary Breast Cancer: A Case of Synchronous Diagnosis and Management of Ductal Carcinoma In Situ and Invasive Ductal Carcinoma
Abstract
Aims/Background Bilateral breast cancer (BBC) is an uncommon subtype of breast cancer which occurs either synchronously or metachronously. Synchronous BBC with distinct histological types in the left and right breasts is particularly rare. Case Presentation This report presents a case of a 57-year-old female patient diagnosed with bilateral primary breast cancer, characterized by ductal carcinoma in situ (DCIS) in one breast and invasive ductal carcinoma (IDC) in the other. The patient initially sought medical attention due to a palpable mass and pain in her left breast, leading to a diagnosis confirmed through imaging studies and biopsy. The patient was treated with three cycles of neoadjuvant therapy, followed by a modified radical mastectomy on the left breast and a lumpectomy on the right breast. Postoperatively, the patient received endocrine therapy and radiotherapy, with no evidence of recurrence observed to date. Conclusion Further research and clinical advancements are necessary to optimize treatment and care strategies for patients with bilateral breast cancer, ensuring that their unique therapeutic needs are effectively addressed.
Keywords: breast neoplasms; case report; ductal carcinoma in situ; invasive ductal carcinoma; neoadjuvant therapy.
Similar articles
-
Feasibility and Prognostic Analysis of Neoadjuvant Therapy Followed by Breast-Conserving Surgery for Invasive Ductal Carcinoma Combined with Ductal Carcinoma in Situ.J Invest Surg. 2025 Dec;38(1):2547226. doi: 10.1080/08941939.2025.2547226. Epub 2025 Sep 1. J Invest Surg. 2025. PMID: 40888169
-
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.Breast Cancer. 2021 Jul;28(4):896-903. doi: 10.1007/s12282-021-01225-0. Epub 2021 Feb 18. Breast Cancer. 2021. PMID: 33599914 Free PMC article.
-
DCIS-like invasive carcinoma of the breast with tumour-associated microvasculature mimicking myoepithelium: a diagnostic pitfall.Histopathology. 2025 Aug;87(2):246-257. doi: 10.1111/his.15459. Epub 2025 May 4. Histopathology. 2025. PMID: 40320387
-
Post-operative radiotherapy for ductal carcinoma in situ of the breast.Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000563. doi: 10.1002/14651858.CD000563.pub6. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2013 Nov 21;(11):CD000563. doi: 10.1002/14651858.CD000563.pub7. PMID: 19821272 Updated.
-
Post-operative radiotherapy for ductal carcinoma in situ of the breast.Cochrane Database Syst Rev. 2009 Jul 8;(3):CD000563. doi: 10.1002/14651858.CD000563.pub5. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000563. doi: 10.1002/14651858.CD000563.pub6. PMID: 19588320 Updated.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical